Huaxia Eye Hospital Group Co.,Ltd.

SZSE:301267 Stock Report

Market Cap: CN¥21.2b

Huaxia Eye Hospital GroupLtd Past Earnings Performance

Past criteria checks 5/6

Huaxia Eye Hospital GroupLtd has been growing earnings at an average annual rate of 21.1%, while the Healthcare industry saw earnings growing at 6.7% annually. Revenues have been growing at an average rate of 21% per year. Huaxia Eye Hospital GroupLtd's return on equity is 11.9%, and it has net margins of 16.5%.

Key information

21.1%

Earnings growth rate

18.1%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate21.0%
Return on equity11.9%
Net Margin16.5%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Huaxia Eye Hospital GroupLtd (SZSE:301267) Seems To Use Debt Rather Sparingly

Feb 29
Huaxia Eye Hospital GroupLtd (SZSE:301267) Seems To Use Debt Rather Sparingly

Revenue & Expenses Breakdown
Beta

How Huaxia Eye Hospital GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:301267 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 244,0616721,02572
31 Dec 234,01366699570
30 Sep 233,81367293375
30 Jun 233,64863086769
31 Mar 233,35555078656
31 Dec 223,23351276249
30 Sep 223,29751676247
01 Jan 223,06445571725
30 Sep 212,99844567522
31 Dec 202,51533459120
31 Dec 192,45621868219
31 Dec 182,14616462114
31 Dec 171,5437849511

Quality Earnings: 301267 has high quality earnings.

Growing Profit Margin: 301267's current net profit margins (16.5%) are higher than last year (16.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 301267's earnings have grown significantly by 21.1% per year over the past 5 years.

Accelerating Growth: 301267's earnings growth over the past year (22.1%) exceeds its 5-year average (21.1% per year).

Earnings vs Industry: 301267 earnings growth over the past year (22.1%) exceeded the Healthcare industry -2.6%.


Return on Equity

High ROE: 301267's Return on Equity (11.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.